UBS Upgrade Lands One Week Before the Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CLH enters its October 28 earnings release with a fresh upgrade from UBS and rising analyst targets, while the stock itself has slipped a fraction over the past week against peers that are broadly climbing.
The analyst move this week is the standout. UBS lifted CLH to Buy from Neutral this morning and raised its target to $375 from $325, a $50 jump that doubles as a conviction call one week before the quarter lands. That follows TD Cowen lifting to $390 on October 14 and Citigroup nudging its target to $378 on October 15, both maintaining existing Buy ratings. The direction of travel is clear: of the four changes in the past two weeks, three are outright constructive. The Street's mean target now stands at $361, roughly 14% above the current price of $316.28. The one outlier remains Barclays, which held its Equal-Weight at $335 on October 8, a target already below where the stock trades. Wells Fargo's Equal-Weight at $349 tells a similar story on valuation caution. The bull case rests on environmental services momentum, PFAS-related project flow, and balance-sheet capacity for acquisitions. Bears point to Safety-Kleen re-refined oil softness and a P/E of 31.2 with an EV/EBITDA near 13.1x, both of which have eased slightly over the past 30 days as the stock drifted.
Lending conditions offer no drama here. Short interest at 2% of the free float is low by any standard, down about 3% on the week and effectively flat over the past month in absolute terms. Borrowing costs ticked up 52% week-on-week to 0.43%, a move that sounds striking until you see where it started: from a base of 0.28% seven days ago, the absolute level remains trivially cheap. Availability is effectively uncapped, with far more shares available to borrow than the entire short position. There is no squeeze dynamic, no shortage of supply, and nothing in the lending market to complicate the earnings setup. Options tell a similar relaxed story: the put/call ratio at 0.52 is slightly below its 20-day average of 0.57, putting it nearly one standard deviation into call territory. Relative to the past year's range, that is firmly in the bullish half of the dial.
CLH's own short score has edged down from 32.2 on October 14 to 31.6 today, a modest drift toward lower short conviction. That places it in the 64th percentile by short score rank within its universe. EPS momentum is a genuine strength: the 30-day and 90-day readings rank in the 83rd and 84th percentiles respectively, and the company's track record of beating estimates ranks in the 82nd percentile on EPS surprise. The one factor that stands out negatively is forward earnings growth: the 12-month forward year-on-year EPS increase ranks in just the 32nd percentile, consistent with a company the market is pricing for quality execution rather than explosive growth.
CLH fell 0.3% on the week. Close peers WCN and RSG rose 10.3% and 5.9% respectively. WM added 9.4%. The gap is notable: Clean Harbors underperformed the three most correlated US waste and environmental peers by a wide margin over the past five sessions. The previous trader note from October 14 flagged a constructive Street and call-heavy options setup, both of which remain intact. What has changed is the UBS upgrade, which adds a bellwether voice to the chorus just before the print.
The July quarter showed the stock moving 4.4% higher on the day results landed. The October 28 release is the next natural test of whether that pattern continues, and the UBS target of $375 sets a visible marker the Street will measure the quarter against.
Stocks in this article
See the live data behind this article on ORTEX.
Open CLH on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 18:17
- Data as of
- 21 Oct 2026, 18:12
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.